|
Volumn 132, Issue 1 II, 1996, Pages 244-250
|
Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
LISINOPRIL;
CONFERENCE PAPER;
CORONARY RISK;
DRUG EFFECT;
DRUG EFFICACY;
HEART INFARCTION;
HEART MUSCLE;
HUMAN;
MORTALITY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
|
EID: 0030054717
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-8703(96)90560-8 Document Type: Conference Paper |
Times cited : (6)
|
References (0)
|